Skip to main
MCK

McKesson (MCK) Stock Forecast & Price Target

McKesson (MCK) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 38%
Hold 23%
Sell 0%
Strong Sell 0%

Bulls say

McKesson is a strong player in the pharmaceutical distribution industry, with a successful track record and plans for sustained growth. The company's focus on sustainability and innovation, as well as its expansion into Canada, provides a strong foundation for future success. However, it also faces potential risks such as declining revenue and potential legislation changes, which must be carefully monitored. Nevertheless, McKesson's solid financials and strategic investments make it an attractive choice for investors with a positive long-term outlook.

Bears say

McKesson is expected to overcome its RxTS challenges and boost revenue through its strong performance in the GLP-1 market and contributions from the growing demand for generics. However, sustainability challenges in opioid distribution and human capital management pose significant risks for the company. Despite these risks, strategic initiatives, and strong leadership are expected to result in high returns for investors as the company plans to expand their services and technology solutions in the healthcare industry, with a focus on higher-growth opportunities in the oncology sector.

McKesson (MCK) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 38% recommend Buy, 23% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of McKesson and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About McKesson (MCK) Forecast

Analysts have given McKesson (MCK) a Buy based on their latest research and market trends.

According to 13 analysts, McKesson (MCK) has a Buy consensus rating as of Sep 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $962.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $962.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

McKesson (MCK)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.